Recombinant Human Usherin (USH2A), partial
-
中文名称:人USH2A重组蛋白
-
货号:CSB-YP025687HU
-
规格:
-
来源:Yeast
-
其他:
-
中文名称:人USH2A重组蛋白
-
货号:CSB-EP025687HU
-
规格:
-
来源:E.coli
-
其他:
-
中文名称:人USH2A重组蛋白
-
货号:CSB-EP025687HU-B
-
规格:
-
来源:E.coli
-
共轭:Avi-tag Biotinylated
E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.
-
其他:
-
中文名称:人USH2A重组蛋白
-
货号:CSB-BP025687HU
-
规格:
-
来源:Baculovirus
-
其他:
-
中文名称:人USH2A重组蛋白
-
货号:CSB-MP025687HU
-
规格:
-
来源:Mammalian cell
-
其他:
产品详情
-
纯度:>85% (SDS-PAGE)
-
基因名:
-
Uniprot No.:
-
别名:USH2A; Usherin; Usher syndrome type IIa protein; Usher syndrome type-2A protein
-
种属:Homo sapiens (Human)
-
蛋白长度:Partial
-
蛋白标签:Tag type will be determined during the manufacturing process.
The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially. -
产品提供形式:Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand. -
复溶:We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
-
储存条件:Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
-
保质期:The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C. -
货期:Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
-
注意事项:Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
-
Datasheet :Please contact us to get it.
靶点详情
-
功能:Involved in hearing and vision as member of the USH2 complex. In the inner ear, required for the maintenance of the hair bundle ankle formation, which connects growing stereocilia in developing cochlear hair cells. In retina photoreceptors, the USH2 complex is required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport.
-
基因功能参考文献:
- A broad spectrum of USH2a copy number variants was identified in Usher syndrome patients. PMID: 29655801
- We report here novel homozygous mutations in various genes causing USH, extending the spectrum of causative mutations. We also prove combined sequencing techniques as useful tools to identify novel disease-causing mutations. To the best of our knowledge, this is the largest report of a genetic analysis of Israeli and Palestinian families (n = 74) with different USH subtypes. PMID: 29490346
- The visual outcome for non-syndromic RP or USH2 patients with USH2A mutations is consistent with that for RP patients with EYS mutations. PMID: 28678594
- Family study implicating mutations in GJB2 and USH2A in Usher's syndrome with congenital hearing loss PMID: 29151245
- Multiple genes contributing to the retinal dystrophy genotypes within a family were discovered using retinal gene-targeted next-generation sequencing. Families with noted examples of phenotypic variation or apparent non-penetrant individuals may offer a clue to suspect complex inheritance. PMID: 28761320
- two truncating mutations combine in USH2A to cause more severe and progressive hearing impairment in Usher syndrome type IIa PMID: 27318125
- The current study confirmed a more severe progression of the retinal disease in USH1 patients rather than in USH2 patients. PMID: 27828912
- 7 patients clinically classified as having USH2, genetic tests confirmed the USH2 diagnosis in 5 cases. Of these, 4 patients showed mutations in the USH2A gene and 1 patient in the ADGRV1 gene. The mutation of the ADGRV1/GPR98 gene has an extremely rare incidence and is associated with a diagnosis of USH type 2C. PMID: 28653555
- In summary, our studies provide novel insight into the functional relationship between USH1 and USH2 proteins in the cochlea and the retina as well as the disease mechanisms underlying USH1 and USH2. PMID: 28031293
- We identified four novel CNVs in three different genes (one duplication in USH2A gene, two duplications in CEP290 gene, and one duplication in RIMS2 gene) in total four families, at a detection rate of 8% (4/50). PMID: 28118666
- Most patients with USH2A-associated RP have severe visual impairment by age 50. However, those with Usher syndrome type IIa have an earlier decline of visual function and a higher cumulative risk of visual impairment than those without nonsyndromic RP. PMID: 26927203
- Protein-protein interaction assays and co-expression of complex partners reveal that pathogenic mutations in USH1G severely affect formation of the SANS/ush2a/whirlin complex. Translational read-through drug treatment, targeting the c.728C > A (p.S243X) nonsense mutation, restored SANS scaffold function. We conclude that USH1 and USH2 proteins function together in higher order protein complexes. PMID: 28137943
- seven out of 27 families, displaying mutations in the ABCA4, RP1, RP2 and USH2A genes, could be genetically or clinically reclassified. These results demonstrate the potential of our panel-based NGS strategy in RP diagnosis PMID: 26806561
- USH2A gene sequencing identifies several new deep intronic mutations responsible for Usher syndrome type 2A. PMID: 26629787
- Usher syndrome 2 is caused by USH2A exon deletions in a small fraction of danish patients. PMID: 25804404
- One novel and two known mutations in the USH2A gene were identified, and were further confirmed by direct sequencing and cosegregation analysis. PMID: 26310143
- The presence of at least one 'retinal disease-specific' USH2A allele in a patient with USH2A-related disease results in the preservation of normal hearing. PMID: 25649381
- Homozygous p.C759F mutations are not pathogenic and this leads to exclude the implication of p.C759F in the RP PMID: 25823529
- Ten variants in the MYO7A gene and 34 variants in the USH2A gene were detected in Italian patients with Usher syndrome at a high detection rate. PMID: 25558175
- Six novel and one recurrent homozygous USH2A mutations were identified with their genotype-phenotype correlations annotated. PMID: 25133613
- The c.8559-2A>G mutation in the USH2A gene is associated the Usher syndrome in a Chinese family. PMID: 26252086
- A homozygous frameshift mutation (c.4382delA, p.T1462Lfs*2) and two compound heterozygous mutations, IVS47 + 1G> A and c.13156A > T (p.I4386F), identified as causative of Usher syndrome in Chinese families. PMID: 26377068
- The novel heterozygous mutations c.8272G>T and c.12376-12378ACT>TAA within the USH2A gene are associated with with Usher syndrome type II. PMID: 26037342
- Novel deletions have been found involving the USH2A gene in patients with Usher syndrome and retinitis pigmentosa. PMID: 25352746
- Herein, we describe 2 siblings harboring the same USH2A mutations (c.[1036A>C];[13316C>T], p.[Asn346His];[Thr4439Ile]) with very different ocular and electrophysiological phenotypes. PMID: 25521520
- Data indicate that Usher syndrome 2A protein (USH2A) mutations was approximately 4% among Japanese autosomal recessive retinitis pigmentosa (arRP), and the USH2A mutations differed largely between Japanese patients and reported Caucasian populations. PMID: 25078356
- Both WHRN and PDZD7 are required for the complex formation with USH2A and GPR98. PMID: 25406310
- Cys759Phe showed P < .001 for most items analyzed when compared with patients carrying p.Glu767Serfs*21 and when compared with patients carrying other mutations in the USH2A gene. PMID: 25375654
- study defined eight additional recurrently mutated genes in SMZL; these genes are CREBBP, CBFA2T3, AMOTL1, FAT4, FBXO11, PLA2G4D, TRRAP and USH2A. PMID: 24349473
- Here, we report an effect of the common c.2299delG mutation on splicing of exons 12 and 13 of USH2A. PMID: 24607488
- Novel Usher syndrome type 2A (USH2A) compound heterozygous mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), located in exons 20 and 70, respectively, were identified as probable causative mutations for retinitis pigmentosa. PMID: 24227914
- Data found pathogenic DNA variants in the genes RP1, USH2A, CNGB3, NMNAT1, CHM, and ABCA4, responsible for retinitis pigmentosa, Usher syndrome, achromatopsia, Leber congenital amaurosis, choroideremia, or recessive Stargardt/cone-rod dystrophy cases. PMID: 23940504
- the genetic defects in the USH2A gene in Usher syndrome families PMID: 23737954
- We found that 8 of 23 (35%) mutations in individuals with a monoallelic mutation in USH2A can be attributed to deletions, duplications and a pathogenic deep intronic variant in patients with usher syndrome. PMID: 23924366
- USH2A (c.2276 G>T) is the likely disease-causing gene in two non-consanguineous Australian pedigrees with autosomal recessive retinitis pigmentosa. PMID: 22876132
- Touch sensitivity was impaired in a cohort of individuals carrying pathogenic mutations in the USH2A gene, but not in other cases of Usher syndrome. PMID: 22563300
- Mutation found in USH2A, GPR98, or DFNB31 account for the vast majority of USH2 patients and their analysis provide a robust pathway for routine molecular diagnosis. PMID: 22147658
- Results establish the mutational frequencies for the short isoform of USH2A gene in Usher syndrome type II. PMID: 22159486
- USH2A sequencing in three affected members of a large family, referred for the recessive USH2 syndrome, identified a single pathogenic alteration in one of them and a different mutation in the two affected nieces. PMID: 22009552
- Mutations in USH2A are responsible for 76.1% of USH2 disease in patients of Spanish origin. PMID: 22004887
- the mutation spectrum for USH2A among Japanese patients largely differs from Caucasian, Jewish and Palestinian patients. PMID: 21593743
- Seven novel mutations (two missense, one 7-bp deletion, two small deletions, and two nonsense) were detected in the four Chinese families after sequencing analysis of USH2A. PMID: 21686329
- 35 USH2A gene deleterious mutations in patients with USH2 were identified including 17 nonsense mutations, 9 frameshift mutations, 5 splice-site mutations, and 4 small in-frame deletions or insertions. Twenty-seven mutations were novel. PMID: 20507924
- An exhaustive c.2299delG/control haplotype study suggests that the major source of variability in the USH2A gene is recombination. PMID: 20145675
- The heterozygous mutation and the homozygous mutation in USH2A may cause Usher syndrome Type II or retinitis pigmentosa, respectively. PMID: 20309401
- Data support the fact that c.2299delG/p.E767fs is indeed the most common USH2A mutation found in USH2 patients of European Caucasian background. PMID: 19881469
- Conservation of usherin is seen at the nucleotide and amino acid level when comparing the mouse and human gene sequences. Evolutionary conservation of usherin expression supports the important structural and functional role usherin plays in human. PMID: 12433396
- There is considerable phenotypic heterogeneity arising from missense mutations, nonsense codons, amino acid substitutions, and polymorphisms in USH2A and ranges from the Usher syndrome, to non-syndromic retinitis pigmentosa, to unaffected subjects. PMID: 12525556
- Comparative analysis of both phenotypic and genotypic data supports the hypothesis that sensorineural hearing loss in patients with Retinitis Pigmentosa may depend on the nature and on the association of the USH2A allele variants present. PMID: 14970843
- Mutation analysis in 12 unrelated patients with Usher syndrome, each with one mutation in exons 1-21, revealed three different truncating mutations in four patients and two missense mutations in one patient PMID: 15015129
显示更多
收起更多
-
相关疾病:Usher syndrome 2A (USH2A); Retinitis pigmentosa 39 (RP39)
-
亚细胞定位:Cell projection, stereocilium membrane; Single-pass type I membrane protein.; [Isoform 2]: Secreted.
-
组织特异性:Present in the basement membrane of many, but not all tissues. Expressed in retina, cochlea, small and large intestine, pancreas, bladder, prostate, esophagus, trachea, thymus, salivary glands, placenta, ovary, fallopian tube, uterus and testis. Absent in
-
数据库链接:
Most popular with customers
-
Recombinant Human CD40 ligand (CD40LG), partial (Active)
Express system: Mammalian cell
Species: Homo sapiens (Human)
-
Recombinant Mouse Prolactin receptor (Prlr), partial (Active)
Express system: Mammalian cell
Species: Mus musculus (Mouse)
-
Recombinant Macaca mulatta Microtubule-associated protein tau (MAPT) (Active)
Express system: Mammalian cell
Species: Macaca mulatta (Rhesus macaque)
-
Recombinant Human Dickkopf-related protein 1 (DKK1) (Active)
Express system: Mammalian cell
Species: Homo sapiens (Human)
-
Recombinant Macaca fascicularis lymphocyte antigen 6 family member G6D (LY6G6D) (Active)
Express system: Yeast
Species: Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)
-
Recombinant Human Tumor-associated calcium signal transducer 2 (TACSTD2), partial (Active)
Express system: Mammalian cell
Species: Homo sapiens (Human)
-
Recombinant Human Cell adhesion molecule 1 (CADM1), partial (Active)
Express system: Mammalian cell
Species: Homo sapiens (Human)
-
Recombinant Human Cadherin-17 (CDH17), partial (Active)
Express system: Mammalian cell
Species: Homo sapiens (Human)